StemFit®AK03N is a growth medium for ES / iPS cells, jointly developed by Ajinomoto and CiRA (Center for iPS cell research and application, Kyoto University). AK03N is free of human and animal-derived components, and PMDA* has confirmed its eligibility for use in cell therapy. AK03N is a high-quality product manufactured using Ajinomoto technology, and has been confirmed by CGT Catapult to have superior performance than other commercially available media, and is widely used for iPS/ES cell production in clinical research.
AK03N is commercially available only in Japan, while Basic03 is available globally.
AK03N is composed of liquid A, B and C. Liquid A and B is completely the same as Basic03, and Liquid C is a bFGF supplement. Therefore, Basic03 becomes the same composition as AK03N by adding bFGF to Basic03.